(600538)"Beihai Gofar Chuanshan Biological Co., Ltd."Report for Q3 2026
Filed with SSE · Stock code 600538 · · 12 pages · Chinese
Summary by 6ix AI
The report confirms that the financial data has not been audited and includes key figures such as revenue and net profit. It highlights a significant increase in net profit compared to the same period last year, alongside a decrease in cash flow from operating activities. The report also discusses the company's ongoing stock issuance plans and recent acquisitions to enhance its operational structure.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Beihai Gofar Chuanshan Biological Co. Ltd. on 6ix
Earlier from Beihai Gofar Chuanshan Biological
- (600538)"Beihai Gofar Chuanshan Biological Co., Ltd."Special Report on the Use of Previously Raised Funds
- (600538)"Beihai Gofar Chuanshan Biological Co., Ltd."Notice on Convening the 1st Extraordinary General Meeting in 2026
- (600538)"Beihai Gofar Chuanshan Biological Co., Ltd."Indicative Announcement on Disclosure of the Proposal for the 2026 Private Placement of A-Shares under the Simplified Procedure
- (600538)"Beihai Gofar Chuanshan Biological Co., Ltd."Announcement on the Dilution of Immediate Returns, Measures to Mitigate Such Dilution and the Undertakings by Relevant Parties in Relation to the 2026 Private Placement of A-Shares under the Simplified Procedure
- (600538)"Beihai Gofar Chuanshan Biological Co., Ltd."Announcement on Resolutions of the 5th Meeting of the 12th Board of Directors
Later from Beihai Gofar Chuanshan Biological
- (600538)"Beihai Gofar Chuanshan Biological Co., Ltd."Announcement on Change of Signing Certified Public Accountant
- (600538)"Beihai Gofar Chuanshan Biological Co., Ltd."Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
Follow Beihai Gofar Chuanshan Biological into a list and get an email when it puts out news.
Follow Beihai Gofar Chuanshan Biological